Navigation Links
Aimago Strengthens and Expands IP Portfolio
Date:8/26/2013

LAUSANNE, Switzerland, Aug. 26, 2013 /PRNewswire-iReach/ -- Aïmago SA, a Swiss medical device company and developer of the Aïmago EasyLDI Perfusion Camera, announces that a core patent for the real-time and non-invasive skin perfusion visualization has been granted in the US. As a result, Aïmago has completed a technology transfer process with the Swiss Federal Institute of Technology in Lausanne (EPFL), including the license of patent applications on the integration of Laser Doppler Imaging (LDI) with ICG / fluorescence imaging.

This further strengthens Aïmago's position as technology leader in clinically relevant perfusion imaging to assess both skin perfusion and deep tissue / organ perfusion within one device.

Granted Patent Protects LDI Ready for Effortless Clinical Use

The recently granted patent (US 8,480,579 B2) protects Aïmago's EasyLDI Perfusion Camera's ability to make LDI real-time by replacing the traditionally used and slow scanning systems with Aïmago's innovative, fast and full-field imaging approach.  Aïmago's patented technology enables EasyLDI to be compact and provide highly intuitive and real-time images for use by surgeons, physicians and nurses.

Combining the Best of Both Worlds

EasyLDI is based on LDI and the most advanced solution for skin perfusion assessment across plastic and reconstructive surgery, burns and advanced wound care, as well as peripheral vascular and extremity applications. It is non-invasive and allows for immediate and continuous imaging much like using a digital camera – both inside and outside the operating room.

In parallel, ICG / fluorescence based perfusion imaging is widely available and an established standard in ophthalmology and neurosurgery. Contrary to LDI, ICG requires the injection of a dye and thus cannot be used continuously, but it has the ability to visualize blood flow in large vessels and inner organs.

While the principle of ICG / fluorescent based perfusion imaging is in public domain, the now licensed patent applications seek to protect the combination of LDI with ICG / fluorescence imaging into one single imaging device. These patent applications, filed in 2007, are currently in review phases in both the United States and Germany.

Prof. Theo Lasser, head of the EPFL Biomedical Optics Lab and co-founder of Aïmago, has experience with ICG and comments: "We are satisfied to see that Aïmago now has access to the entire IP package. From a clinical perspective, the implemented LDI modality covers the majority of applications related to skin perfusion imaging, while ICG / fluorescence imaging opens the door to deeper tissues and organs – all through one single, highly intuitive instrument."

About Aïmago

Aïmago is a privately held, medical device company founded as a spin-off from EPFL in 2008. The tablet-inspired and FDA cleared Aïmago EasyLDI Perfusion Camera empowers clinicians and nurses to obtain clinically relevant, objective and repeatable insights into the perfusion reality. Emphasizing on usability, EasyLDI essentially works like a point-and-shoot camera: No injections, no turning-off the ambient light, no extra personnel, no waiting, and no limitations to use. The company has won several awards, including the CTI MedTech Award 2011 from the Swiss government and the W.A. de Vigier Award for best Swiss start-up. More information is available at www.aimago.com.

Media Contact: Michael Friedrich, Aïmago SA, +41215105560, michael.friedrich@aimago.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Aïmago SA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
2. OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria
3. Global Pharmaceutical Company Strengthens Compliance Using Vault PromoMats and Veeva CRM
4. TransCelerate BioPharma Inc. Grows, Strengthens Novel Effort to Accelerate Drug Development
5. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
6. Alliqua Strengthens and Realigns Executive Team
7. inVentiv Health Strengthens Clinical Leadership Team
8. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
9. Pharmalink AB Strengthens Senior Management Team
10. Actinium Pharmaceuticals Strengthens Management Team
11. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... NEW YORK , March 29, 2017 ... ... society and the public safety in regulating marijuana, but economic ... revenues, job creation, and reduced law enforcement costs. However, to ... like those provided by SinglePoint, Inc. (OTC: SING) ( SING ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... The global emerging cancer diagnostics market is ... 2016 to 2023 and reach a figure of $6.34 ... a chronic disease and is affecting a huge population. ... This report is focused on emerging cancer diagnostics market ... propelled due to factors such as: increasing number of ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 ... Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while ... HeartBoost, an over the counter heart healthy drink, can reduce Arterial Plaque, Lower ...
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a ... treatment and accepting new pediatric patients, with or without a referral. Dr. Cotey knows ... a better orthodontic outcome and experience. When patients receive early treatment, they may achieve ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a premium medical cannabis ... the company’s executive management team with prominent executives from both inside and outside the ... Operating Officer, Ted Dumbauld , who has more than twenty years of business ...
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, 2017 , ... ... treatment of a growing number of cancers and is touted to be the next ... of treatment, thus far, has been in the form of immune checkpoint inhibitors such ...
(Date:3/29/2017)... ... , ... The Wharton School of the University of Pennsylvania is pleased to ... $10 million gift to establish the Ken Moelis and Julie Taffet Moelis Advance ... Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional notions ...
Breaking Medicine News(10 mins):